| 1 |
33741979 | Clinical impact of subclonal EGFR T790M mutations in advanced-stage EGFR-mutant non-small-cell lung cancers. | 2021 Mar 19 |
1 |
| 2 |
34590028 | Brief Report: Heterogeneity of Acquired Resistance Mechanisms to Osimertinib and Savolitinib. | 2021 Jun |
1 |
| 3 |
32793495 | Longitudinal Monitoring of EGFR and PIK3CA Mutations by Saliva-Based EFIRM in Advanced NSCLC Patients With Local Ablative Therapy and Osimertinib Treatment: Two Case Reports. | 2020 |
1 |
| 4 |
31414729 | Plasma next generation sequencing and droplet digital PCR-based detection of epidermal growth factor receptor (EGFR) mutations in patients with advanced lung cancer treated with subsequent-line osimertinib. | 2019 Oct |
1 |
| 5 |
29506987 | Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients. | 2018 Jul 1 |
1 |